The Rocky Mountain MS Center is aSLOW Food Denver C.A.F.E. Grant Finalist! Support the Rocky Mountain MS Center and the King Adult Day Enrichment Program (KADEP) by joining us for…
Read More
Participants with multiple sclerosisare needed for a research study on:Arbaclofen (an extended release anti-spasticity investigational medication) Purpose of the study – Researchers from the University of Colorado Anschutz Medical Campus…
This month, Dr. Alvarez became the newest member of the Rocky Mountain MS Center at Anschutz Medical Campus team—making him the seventh fellowship-trained MS specialist on staff. Please tell us about…
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. In people with MS, specific immune system cells (T-cells) misidentify elements of the brain and spinal cord as…
InforMS – Summer 2013 Featured Article: Brain Drain MS cognitive problems are common, confusing,usually mild, mostly manageable and always draining. Welcome to the 2013 DIGITAL Summer Issue…
InforMS – Summer 2013 Featured Article: Brain Drain MS cognitive problems are common, confusing,usually mild, mostly manageable and always draining. Welcome to the 2013 DIGITAL Summer Issue…
Share this: Participants with multiple sclerosis are needed for a research study on: PET/CT imaging of leg muscles after walking Researchers from the University of Colorado Anschutz Medical Campus and…
Share this: Multiple Summits for Multiple Sclerosis (MS4MS) 2013 It is almost August and MS4MS 2013 is off to a great start! There is still plenty of time to register…
BG-12, an oral treatment for relapsing-remitting forms of multiple sclerosis, has received FDA approval and will be sold under the name Tecfidera. Manufactured by Biogen Idec, it is the third…
Multiple Scleresis: Colorado Pediatric Study On April 2, 2013 CBS aired a story about MS in children. During the interview Sr. Teri Schriener was interviewed. Learn more about what…